Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.
Saved in:
| Title: | Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults. |
|---|---|
| Authors: | Silman D; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Flaxman A; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Datoo M; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Edwards NJ; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Ramos-Lopez F; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Mitton C; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Mair C; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Bellamy D; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Bowyer G; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Morter R; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Halbroth B; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Venkatraman N; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Folegatti PM; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Marshall J; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Poulton I; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Bajer A; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Salman AM; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Berrie E; Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, England, OX3 7JT, UK., Baum J; Department of Life Sciences, Imperial College London Faculty of Natural Sciences, London, England, SW7 2AZ, UK.; School of Biomedical Sciences, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, 2052, Australia., Blagborough AM; Department of Life Sciences, Imperial College London Faculty of Natural Sciences, London, England, SW7 2AZ, UK.; University of Cambridge Department of Pathology, Cambridge, England, CB1 2QP, UK., Crocker W; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Roberts R; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Lawrie AM; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, England, OX3 7LJ, UK., Spencer AJ; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; School of Biomedical Science and Pharmacy, The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, 2308, Australia., Gilbert SC; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK., Ewer KJ; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK.; Global Health Vaccines R&D, GSK Vaccines Institute for Global Health, Siena, Italy., Hill AVS; Jenner Institute, Nuffield Department of Medicine, NIHR Biomedical Research Centre, University of Oxford Nuffield Department of Medicine, Oxford, England, OX3 7DQ, UK. |
| Source: | Wellcome open research [Wellcome Open Res] 2026 Apr 06; Vol. 9, pp. 734. Date of Electronic Publication: 2026 Apr 06 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
